• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/26

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

26 Cards in this Set

  • Front
  • Back

primary prevention

reduce disease burden of cancer




etiology can avoid cancer




few cancers have such a clear prevention strategy

secondary prevention

altering the natural history of the disease through screening

cancer screening define

tests on apparently healthy individuals to sort out those who probably have risk factors

sojourn time

time between when a tumor could be detected to the time before symptoms onset

lead time

time gained between when symptoms arise and when the tumor was detected from screening

____ leading cause of deaths in the US

2nd

lifetime risk of developing cancer men and women

men: 44.7%


women: 38%



lifetime risk of dying of cancer men and women

men: 23.61%


women: 20.5%

sensitivity define

probability a test detects cancer among asymptomatic individuals who actually have the disease

specificity define

probability a test will correctly identify an healthy individual who doesn't have cancer

testing for disease has at least three components

figuring out who is at risk


screening test


confirmatory test

breast cancer screening

self breast examination - monthly, starting at 20


clinical breast exam - from 20-39 every 3 years


mammogram - annually starting at 40

colorectal cancer screening

starting at 50
-fecal occult blood test


-colonoscopy every 10 years




start at 40 if there is a family history




familial adenomatous polyposis


-start screening at puberty


-colectomy


-otherwise endoscopy every 1-2 years

prostate cancer screening

annual after 50


-prostate specific antigen


-digital rectal exam




percentage of free psa ratio


psa velocity

lung cancer screening

no routine examination




-ct


-chest radiograph




sputum cytology - does not identify site

cervical cancer screening

21-29 - pap smear every 3 years


30-65 - pap smear and HPV every 5 years




if routine testing is not positive after 65 years then should not be screened




women who have had HPV vaccine should still follow the screening recommendatons

endometrial cancer screening

no routine screening


pap smear is not sensitive enough




people usually experience symptoms

ovarian cancer screening

annual pelvic exam beginning at 18 years old


-palpate ovaries


-abdominal ultrasound



testicular cancer screening

poor candidate for control by screening and early detection




highly treatable and curable




high risk: cryptochidism, testicular atrophy, orchiopexy




checkup every 3 years for those over 20 and every year if over 40


-physicial exam


-self detection - low specificity

melanoma and nonmelanoma skin cancer screening

skin exam by trained health professional


-every 3 years 20-39


- annually after 40




high risk: white race, fair complexion, pigmented lesions, xeroderma pigmentosum

cancer grade is based on

degree of differentiation, nuclear features, estimated growth rate based on mitotic rate

cancer staging is based on

features of untreated primary lesion and its metastatic component


-tumor size


-lymph node involvement


-metastasis

objectives of staging

helps plan tx


evaluation of tx modality


facilitates exchange of info between tx centers worldwide


estimates the prognosis for each pt by stage


provides data for research



what staging system is used for hodgkin's lympoma

ann arbor

what staging system is used for GYN neoplasms

fIGO

what staging system is used for colorectal neoplasms

DUKE